News & Events

News &

Tarsier® Pharma receives certificate of registration for trademark Tarsier® in the US & other territories

26 June, 2022

Tarsier Pharma is pleased to announce that on June 21, 2022, the US Patent and Trademark Office has registered Tarsier® as its trademark, namely for ophthalmic drugs. This follows registration of the trademark in other territories.

BizDev Manager, Ruti Friedel, commented: “as a step in strengthening our brand, and for optimal international reach of our products, Tarsier® Pharma has applied for protection of its trademark Tarsier® in international markets. We are glad to have it registered now also in the US, as this would be one of our major markets for our drug candidates.”

Scroll to Top
Skip to content